Temozolomide Capsule
Pricing Report NDC 16571-820-41

View Wholesale Price per Unit, Acquisition Costs, and Historic Pricing Trends
Table of Contents
  1. Current Pricing Information
  2. Pricing History

Current Package Pricing Information

The latest wholesale acquisition cost for Temozolomide (NDC 16571-820-41) is $21.41320 per EA. This benchmark price is based on the National Average Drug Acquisition Cost (NADAC) and has been effective since Mar 19, 2025.

As a a human prescription drug provided by Rising Pharma Holdings, Inc., this medication is distributed in a 14 CAPSULE in 1 BOTTLE configuration. The pricing data is derived from C/I - Chain or Independent Pharmacy surveys, reflecting the actual invoice prices paid by community pharmacies to drug wholesalers.

NADAC Pricing Summary

NADAC pricing snapshot for this package NDC

Acquisition Cost
$21.41320
Per EA

Pricing Unit
Per EA Pricing Unit
Indicates the billing unit (ML, GM or EA).
Effective Date
Mar 19, 2025
Billable Units
14 EA
Estimated Package Price
$299.78
Data Status
As of Mar 11, 2026
Pharmacy Source Pharmacy Type Indicator
Data collected from Chain/Independent pharmacy surveys.
C/I - Chain or Independent Pharmacy
Rate Classification Classification for Rate Setting
Indicates if the NDC is Brand (B) or Generic (G).
G - Generic
Package NDC
16571-820-41
Description
14 CAPSULE in 1 BOTTLE
Pricing Methodology Explanation
The NADAC was carried forward from the previous file.

Historical Pricing Trends & Acquisition Cost Benchmarks

Since Nov 2024, the NADAC wholesale price for (NDC ) has moved within a range of $17.07360 to $21.41320 per EA. Over this 3 months period, the pricing trend reflects the shifting acquisition costs reported by retail and chain pharmacies to the Centers for Medicare and Medicaid Services (CMS). The following interactive chart and historical table detail every recorded price adjustment based on these federal surveys.

Price Range
$17.0736 - $21.4132
Market Volatility
25.42% Variance
Latest Trend
No Change
Date Unit Price Unit Source Method Rate
Mar 19, 2025 $21.41320 EAC/I - Chain or Independent PharmacyCode 1G - Generic
Mar 19, 2025 $21.41320 EAC/I - Chain or Independent PharmacyCode 4G - Generic
Mar 19, 2025 $21.41320 EAC/I - Chain or Independent PharmacyCode 1G - Generic
Mar 19, 2025 $21.41320 EAC/I - Chain or Independent PharmacyCode 4G - Generic
Feb 19, 2025 $21.41320 EAC/I - Chain or Independent PharmacyCode 1G - Generic
Feb 19, 2025 $21.41320 EAC/I - Chain or Independent PharmacyCode 1G - Generic
Jan 22, 2025 $19.96666 EAC/I - Chain or Independent PharmacyCode 1G - Generic
Jan 22, 2025 $19.96666 EAC/I - Chain or Independent PharmacyCode 1G - Generic
Dec 18, 2024 $19.24340 EAC/I - Chain or Independent PharmacyCode 1G - Generic
Dec 18, 2024 $19.24340 EAC/I - Chain or Independent PharmacyCode 1G - Generic
Nov 20, 2024 $17.07360 EAC/I - Chain or Independent PharmacyCode 1G - Generic
Nov 20, 2024 $17.07360 EAC/I - Chain or Independent PharmacyCode 1G - Generic

Pricing Methodology Legend

  • Code 1: The NADAC was calculated using information from the most recently completed pharmacy survey.
  • Code 4: The NADAC was carried forward from the previous file.

Understanding NADAC Pricing Data

The National Average Drug Acquisition Cost (NADAC) is compiled by the Centers for Medicare and Medicaid Services (CMS). This data is derived from random monthly surveys of more than 60,000 pharmacies across all 50 states.

Important Price Distinction:

The prices listed on this page represent the wholesale invoice price paid by pharmacies to acquire the drug. This is NOT the retail price paid by consumers at the pharmacy counter. Final patient costs typically include pharmacy markups, professional dispensing fees, and insurance adjustments.

NADAC Pricing Data Last Updated on: July 08, 2026